Literature DB >> 33837291

Validation of Omron HEM-9200T, a home blood pressure monitoring device for the upper arm, according to the American National Standards Institute/Association for the Advancement of Medical Instrumentation/International Organization for Standardization 81060-2:2013 protocol.

Hakuo Takahashi1,2, Kanako Saito3, Nobuki Yakura3.   

Abstract

The performance of Omron HEM-9200T for monitoring blood pressure (BP) in the upper arm was validated in accordance with the American National Standards Institute/Association for the Advancement of Medical Instrumentation/International Organization for Standardization (ANSI/AAMI/ISO) 81060-2:2013 protocol. The device was assessed by using it on 87 participants who fulfilled the inclusion criteria involving the ranges of arm circumference and systolic and diastolic BP provided by the protocol. Validation and data analysis were performed according to the protocol. In the ANSI/AAMI/ISO 81060-2:2013 validation procedure (criterion 1), the mean ± standard deviation of the differences between the test device and reference BP was -0.1 ± 5.06/1.2 ± 5.8 mmHg (systolic/diastolic). The mean differences between the two observers and Omron HEN-9200T were -0.1 ± 3.82 mmHg for systolic BP and 1.2 ± 5.34 mmHg for diastolic BP, fulfilling criterion 2 with an SD of ≤6.91 for SBP and ≤6.87 for DBP. These two ANSI/AAMI/ISO criteria were fulfilled.The Omron HEM-9200T BP monitor fulfilled the requirements of the ANSI/AAMI/ISO validation standard and can be recommended for BP measurements at home in the general population.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 33837291     DOI: 10.1038/s41371-021-00536-1

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  1 in total

Review 1.  A Universal Standard for the Validation of Blood Pressure Measuring Devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement.

Authors:  George S Stergiou; Bruce Alpert; Stephan Mieke; Roland Asmar; Neil Atkins; Siegfried Eckert; Gerhard Frick; Bruce Friedman; Thomas Graßl; Tsutomu Ichikawa; John P Ioannidis; Peter Lacy; Richard McManus; Alan Murray; Martin Myers; Paolo Palatini; Gianfranco Parati; David Quinn; Josh Sarkis; Andrew Shennan; Takashi Usuda; Jiguang Wang; Colin O Wu; Eoin O'Brien
Journal:  Hypertension       Date:  2018-01-31       Impact factor: 10.190

  1 in total
  2 in total

1.  Impacts of the COVID-19 pandemic on unmet social needs, self-care, and outcomes among people with diabetes and poor glycemic control.

Authors:  Minal R Patel; Guanghao Zhang; Cindy Leung; Peter X K Song; Michele Heisler; Hae Mi Choe; Roshanak Mehdipanah; Xu Shi; Kenneth Resnicow; Geila Rajaee; John D Piette
Journal:  Prim Care Diabetes       Date:  2021-10-29       Impact factor: 2.459

2.  Home blood pressure telemonitoring for improving blood pressure control in middle-aged and elderly patients with hypertension.

Authors:  Jianwei Yue; Xiaomin Yang; Bin Wang; Han Hu; Haiming Fu; Yuxia Gao; Gang Sun
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-08-05       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.